These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23159046)

  • 1. Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementia.
    Vermeiren Y; Le Bastard N; Van Hemelrijck A; Drinkenburg WH; Engelborghs S; De Deyn PP
    Alzheimers Dement; 2013 Sep; 9(5):488-98. PubMed ID: 23159046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia.
    Engelborghs S; Vloeberghs E; Le Bastard N; Van Buggenhout M; Mariën P; Somers N; Nagels G; Pickut BA; De Deyn PP
    Neurochem Int; 2008 May; 52(6):1052-60. PubMed ID: 18093695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical diagnosis of dopaminergic disturbances in paediatric patients: analysis of cerebrospinal fluid homovanillic acid and other biogenic amines.
    Marín-Valencia I; Serrano M; Ormazabal A; Pérez-Dueñas B; García-Cazorla A; Campistol J; Artuch R
    Clin Biochem; 2008 Nov; 41(16-17):1306-15. PubMed ID: 18790694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological and behavioural correlates of CSF biomarkers in dementia.
    Engelborghs S; Maertens K; Vloeberghs E; Aerts T; Somers N; Mariën P; De Deyn PP
    Neurochem Int; 2006 Mar; 48(4):286-95. PubMed ID: 16434124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K
    No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and psychologic symptoms in different types of dementia.
    Chiu MJ; Chen TF; Yip PK; Hua MS; Tang LY
    J Formos Med Assoc; 2006 Jul; 105(7):556-62. PubMed ID: 16877235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain region-specific monoaminergic correlates of neuropsychiatric symptoms in Alzheimer's disease.
    Vermeiren Y; Van Dam D; Aerts T; Engelborghs S; De Deyn PP
    J Alzheimers Dis; 2014; 41(3):819-33. PubMed ID: 24685637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum MHPG strongly predicts conversion to Alzheimer's disease in behaviorally characterized subjects with Down syndrome.
    Dekker AD; Coppus AM; Vermeiren Y; Aerts T; van Duijn CM; Kremer BP; Naudé PJ; Van Dam D; De Deyn PP
    J Alzheimers Dis; 2015; 43(3):871-91. PubMed ID: 25125467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychiatric symptoms of dementia: cross-sectional analysis from a prospective, longitudinal Belgian study.
    Engelborghs S; Maertens K; Nagels G; Vloeberghs E; Mariën P; Symons A; Ketels V; Estercam S; Somers N; De Deyn PP
    Int J Geriatr Psychiatry; 2005 Nov; 20(11):1028-37. PubMed ID: 16250064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural and neuropsychological correlates of frontal lobe features in dementia.
    Engelborghs S; Maertens K; Mariën P; Vloeberghs E; Somers N; Nagels G; De Deyn PP
    Psychol Med; 2006 Aug; 36(8):1173-82. PubMed ID: 16700962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered cerebrospinal fluid amino acid pattern in the anorexia of aging: relationship with biogenic amine metabolism.
    Martinez M; Arnalich F; Vazquez JJ; Hernanz A
    Life Sci; 1993; 53(21):1643-50. PubMed ID: 7694027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal Fluid Concentrations of Neurotransmitters in a Greek Pediatric Reference Population.
    Vilanakis E; Papakonstantinou E; Paramera E; Argyri I; Drakou E; Kokkinou E; Zouvelou V; Outsika C; Pons R
    Neuropediatrics; 2023 Apr; 54(2):126-133. PubMed ID: 36442788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF tau, Aβ42, and MHPG differentiate dementia with Lewy bodies from Alzheimer's disease.
    Aerts MB; Esselink RA; Claassen JA; Abdo WF; Bloem BR; Verbeek MM
    J Alzheimers Dis; 2011; 27(2):377-84. PubMed ID: 21841257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.
    Parnetti L; Tiraboschi P; Lanari A; Peducci M; Padiglioni C; D'Amore C; Pierguidi L; Tambasco N; Rossi A; Calabresi P
    Biol Psychiatry; 2008 Nov; 64(10):850-5. PubMed ID: 18395699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Putative amino acid transmitters in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
    Smith CC; Bowen DM; Francis PT; Snowden JS; Neary D
    J Neurol Neurosurg Psychiatry; 1985 May; 48(5):469-71. PubMed ID: 2860210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventricular cerebrospinal fluid monoamine transmitter and metabolite concentrations reflect human brain neurochemistry in autopsy cases.
    Wester P; Bergström U; Eriksson A; Gezelius C; Hardy J; Winblad B
    J Neurochem; 1990 Apr; 54(4):1148-56. PubMed ID: 1968956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of biogenic amine levels in the Rett syndrome.
    Zoghbi HY; Percy AK; Glaze DG; Butler IJ; Riccardi VM
    N Engl J Med; 1985 Oct; 313(15):921-4. PubMed ID: 2412119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations between cognitive, behavioural and psychological findings and levels of vitamin B12 and folate in patients with dementia.
    Engelborghs S; Vloeberghs E; Maertens K; Mariën P; Somers N; Symons A; Clement F; Ketels V; Saerens J; Goeman J; Pickut BA; Vandevivere J; De Deyn PP
    Int J Geriatr Psychiatry; 2004 Apr; 19(4):365-70. PubMed ID: 15065230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue concentration changes of amino acids and biogenic amines in the central nervous system of mice with experimental autoimmune encephalomyelitis (EAE).
    Musgrave T; Tenorio G; Rauw G; Baker GB; Kerr BJ
    Neurochem Int; 2011 Aug; 59(1):28-38. PubMed ID: 21672584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain Serotonergic and Noradrenergic Deficiencies in Behavioral Variant Frontotemporal Dementia Compared to Early-Onset Alzheimer's Disease.
    Vermeiren Y; Janssens J; Aerts T; Martin JJ; Sieben A; Van Dam D; De Deyn PP
    J Alzheimers Dis; 2016 Jun; 53(3):1079-96. PubMed ID: 27314528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.